Page 9 - Flipbook

Current Treatment Algorithm

Avelumab* Enfortumab

SD/PR/CR
Platinum-Based Vedotin*

Chemotherapy
Taxane
4-6 cycles PD

Pembrolizumab
Erdafitinib**
OR Erdafitinib**

Platinum-ineligible → BSC

• *Currently available by special access program

• **For patients with known FGFR mutations/fusions, limited testing availability